The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670701210) is a paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter designed for the treatment of stenotic lesions in peripheral arteries. This 7 mm x 120 mm configuration combines a low-profile balloon platform with a proprietary drug-excipient coating intended to deliver paclitaxel to the vessel wall during angioplasty.
Key Features
Balloon diameter: 7 mm
Balloon length: 120 mm
Drug coating: Paclitaxel with TransPax excipient technology
Nominal drug dose density: 2 µg/mm² (per manufacturer literature)
Catheter design: Over-the-wire PTA balloon platform
Guidewire compatibility: 0.035 in (per manufacturer literature)
Single-use, sterile device
Clinical Applications
Indicated by the manufacturer for percutaneous transluminal angioplasty of de novo, restenotic, or in-stent restenotic lesions in the peripheral vasculature, including the superficial femoral and popliteal arteries. Refer to the official Instructions for Use for the complete list of indications, contraindications, warnings, and precautions. Not specified in the located sources for off-label or investigational uses.
Product Information
Brand: Boston Scientific
Product line: Ranger Drug-Coated Balloon (DCB)
Category: Peripheral Balloon Catheters
REF/UPN: H74939670701210
Size: 7 mm x 120 mm
Packaging: Single sterile unit; refer to product label for shelf life and storage
Regulatory status: Refer to the manufacturer's official documentation for region-specific clearances and approvals